eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
3/2024
vol. 16
 
Share:
Send email
Share:
Original paper

Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer

Pittaya Dankulchai
1
,
Natthakorn Thanamitsomboon
1
,
Wiwatchai Sittiwong
1
,
Nont Kosaisawe
2
,
Kullathorn Thephamongkhol
1
,
Wisawa Phongprapun
1
,
Tissana Prasartseree
1

  1. Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
  2. Department of Molecular and Cellular Biology, University of California Davis, Davis, USA
J Contemp Brachytherapy 2024; 16, 3: 193–201
DOI: https://doi.org/10.5114/jcb.2024.141458
Online publish date: 2024/06/28
Article file
- Pre-treatment.pdf  [0.26 MB]
Get citation
 
 
1. Lukka H, Hirte H, Fyles A et al. Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer – a meta-analysis. Clin Oncol (R Coll Radiol) 2002; 14: 203-212.
2. Datta NR, Stutz E, Liu M et al. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis. Gynecol Oncol 2017; 145: 374-385.
3. Potter R, Tanderup K, Schmid MP et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 2021; 22: 538-547.
4. Castelnau-Marchand P, Chargari C, Haie-Meder C, Mazeron R. Image-guided adaptive brachytherapy in locally advanced cervical cancer: recent advances and perspectives. Curr Opin Oncol 2016; 28: 419-428.
5. Dankulchai P, Lohasammakul S, Petsuksiri J et al. Dosimetric analysis and preliminary clinical result of image-guided brachytherapy with or without hybrid technique for cervical cancer using VariSource titanium ring applicator with “Siriraj Ring Cap”. Brachytherapy 2017; 16: 1199-1204.
6. Prasartseree T, Dankulchai P, Hoskin PJ. Excess dose-related parameters (Vex, Rex, and iRex): novel predictors and late toxicity correlations in cervical cancer image-guided adaptive brachytherapy. J Contemp Brachytherapy 2020; 12: 441-453.
7. Xie H, Wang J, Chen Y et al. Automatic reconstruction of interstitial needles using CT images in post-operative cervical cancer brachytherapy based on deep learning. J Contemp Brachytherapy 2023; 15: 134-140.
8. Fang J, Zhang B, Wang S et al. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer. Theranostics 2020; 10: 2284-2292.
9. Guo C, Wang J, Wang Y et al. Novel artificial intelligence machine learning approaches to precisely predict survival and site-specific recurrence in cervical cancer: A multi-institutional study. Transl Oncol 2021; 14: 101032.
10. Hou L, Zhou W, Ren J et al. Radiomics analysis of multiparametric MRI for the preoperative prediction of lymph node metastasis in cervical cancer. Front Oncol 2020; 10: 1393.
11. Hu Q, Shi J, Zhang A et al. Added value of radiomics analysis in MRI invisible early-stage cervical cancers. Br J Radiol 2022; 95: 20210986.
12. Huang G, Cui Y, Wang P et al. Multi-parametric magnetic resonance imaging-based radiomics analysis of cervical cancer for preoperative prediction of lymphovascular space invasion. Front Oncol 2021; 11: 663370.
13. Jiang X, Li J, Kan Y et al. MRI based radiomics approach with deep learning for prediction of vessel invasion in early-stage cervical cancer. IEEE/ACM Trans Comput Biol Bioinform 2021; 18: 995-1002.
14. Jiang X, Song J, Duan S et al. MRI radiomics combined with clinicopathologic features to predict disease-free survival in patients with early-stage cervical cancer. Br J Radiol 2022; 95: 20211229.
15. Jha AK, Mithun S, Sherkhane UB et al. Systematic review and meta-analysis of prediction models used in cervical cancer. Artif Intell Med 2023; 139: 102549.
16. Sheehy J, Rutledge H, Acharya UR et al. Gynecological cancer prognosis using machine learning techniques: A systematic review of the last three decades (1990-2022). Artif Intell Med 2023; 139: 102536.
17. Bowen SR, Yuh WTC, Hippe DS et al. Tumor radiomic heterogeneity: Multiparametric functional imaging to characterize variability and predict response following cervical cancer radiation therapy. J Magn Reson Imaging 2018; 47: 1388-1396.
18. Ferreira M, Lovinfosse P, Hermesse J et al. [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. Eur J Nucl Med Mol Imaging 2021; 48: 3432-3443.
19. Ikushima H, Haga A, Ando K et al. Prediction of out-of-field recurrence after chemoradiotherapy for cervical cancer using a combination model of clinical parameters and magnetic resonance imaging radiomics: a multi-institutional study of the Japanese Radiation Oncology Study Group. J Radiat Res 2022; 63: 98-106.
20. Lucia F, Visvikis D, Desseroit MC et al. Prediction of outcome using pretreatment (18)F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy. Eur J Nucl Med Mol Imaging 2018; 45: 768-786.
21. Liu B, Sun Z, Xu ZL et al. Predicting disease-free survival with multiparametric MRI-derived radiomic signature in cervical cancer patients underwent CCRT. Front Oncol 2021; 11: 812993.
22. Liu S, Li R, Liu Q et al. Radiomics model of 18F-FDG PET/CT imaging for predicting disease-free survival of early-stage uterine cervical squamous cancer. Cancer Biomark 2022; 33: 249-259.
23. Reuze S, Orlhac F, Chargari C et al. Prediction of cervical cancer recurrence using textural features extracted from 18F-FDG PET images acquired with different scanners. Oncotarget 2017; 8: 43169-43179.
24. Wei C, Xiang X, Zhou X et al. Development and validation of an interpretable radiomic nomogram for severe radiation proctitis prediction in postoperative cervical cancer patients. Front Microbiol 2022; 13: 1090770.
25. Zhang Y, Zhang K, Jia H et al. IVIM-DWI and MRI-based radiomics in cervical cancer: Prediction of concurrent chemoradiotherapy sensitivity in combination with clinical prognostic factors. Magn Reson Imaging 2022; 91: 37-44.
26. Murali S, Ding H, Adedeji F et al. Bringing MRI to low- and middle-income countries: Directions, challenges and potential solutions. NMR Biomed 2024; 37: e4992.
27. Jajodia A, Gupta A, Prosch H et al. Combination of radiomics and machine learning with diffusion-weighted MR imaging for clinical outcome prognostication in cervical cancer. Tomography 2021; 7: 344-357.
28. Laliscia C, Gadducci A, Mattioni R et al. MRI-based radiomics: promise for locally advanced cervical cancer treated with a tailored integrated therapeutic approach. Tumori 2022; 108: 376-385.
29. Takada A, Yokota H, Watanabe Nemoto M et al. A multi-scanner study of MRI radiomics in uterine cervical cancer: prediction of in-field tumor control after definitive radiotherapy based on a machine learning method including peritumoral regions. Jpn J Radiol 2020; 38: 265-273.
30. Kawahara D, Nishibuchi I, Kawamura M et al. Radiomic analysis for pretreatment prediction of recurrence post-radiotherapy in cervical squamous cell carcinoma cancer. Diagnostics (Basel) 2022; 12: 2346.
31. Traverso A, Kazmierski M, Welch ML et al. Sensitivity of radiomic features to inter-observer variability and image pre-processing in Apparent Diffusion Coefficient (ADC) maps of cervix cancer patients. Radiother Oncol 2020; 143: 88-94.
32. Donati OF, Chong D, Nanz D et al. Diffusion-weighted MR imaging of upper abdominal organs: field strength and intervendor variability of apparent diffusion coefficients. Radiology 2014; 270: 454-463.
33. Boca SM, Leek JT. A direct approach to estimating false discovery rates conditional on covariates. PeerJ 2018; 6: e6035.
34. Park SH, Lim H, Bae BK et al. Robustness of magnetic resonance radiomic features to pixel size resampling and interpolation in patients with cervical cancer. Cancer Imaging 2021; 21: 19.
35. Da-Ano R, Lucia F, Masson I et al. A transfer learning approach to facilitate ComBat-based harmonization of multicentre radiomic features in new datasets. PLoS One 2021; 16: e0253653.
36. Esfahani SA, Torrado-Carvajal A, Amorim BJ et al. PET/MRI and PET/CT radiomics in primary cervical cancer: A pilot study on the correlation of pelvic PET, MRI, and CT derived image features. Mol Imaging Biol 2022; 24: 60-69.
37. Wang J, Mao Y, Gao X, Zhang Y. Recurrence risk stratification for locally advanced cervical cancer using multi-modality transformer network. Front Oncol 2023; 13: 1100087.
38. Cusumano D, Russo L, Gui B et al. Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images. Radiother Oncol 2022; 174: 30-36.
39. Zhang X, Zhao J, Zhang Q et al. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy. Cancer Imaging 2022; 22: 35.
40. Ranganathan P, Pramesh CS, Buyse M. Common pitfalls in statistical analysis: The perils of multiple testing. Perspect Clin Res 2016; 7: 106-107.
41. Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt 2014; 34: 502-508.
42. Esfahani SA, Torrado-Carvajal A, Amorim BJ et al. Publisher correction to: PET/MRI and PET/CT radiomics in primary cervical cancer: A pilot study on the correlation of pelvic PET, MRI, and CT derived image features. Mol Imaging Biol 2022; 24: 70.
43. Meng J, Zhu L, Zhu L et al. Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy. Radiat Oncol 2016; 11: 141.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.